0.61
+0.0416(+7.30%)
Currency In USD
| Previous Close | 0.57 |
| Open | 0.56 |
| Day High | 0.7 |
| Day Low | 0.53 |
| 52-Week High | 14.08 |
| 52-Week Low | 0.12 |
| Volume | 263.22M |
| Average Volume | 87.55M |
| Market Cap | 114.3M |
| PE | -0.01 |
| EPS | -80.39 |
| Moving Average 50 Days | 0.19 |
| Moving Average 200 Days | 2.46 |
| Change | 0.04 |
If you invested $1000 in Tonix Pharmaceuticals Holding Corp. (TNXP) 10 years ago, it would be worth $0 as of December 21, 2024 at a share price of $0.612. Whereas If you bought $1000 worth of Tonix Pharmaceuticals Holding Corp. (TNXP) shares 5 years ago, it would be worth $0.09 as of December 21, 2024 at a share price of $0.612.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
GlobeNewswire Inc.
Dec 17, 2024 1:00 PM GMT
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review has been granted in the Day 74 Letter TNX-102 SL is a non-opioid, centrally acting analgesic, granted Fast Track designation by
Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires
GlobeNewswire Inc.
Dec 03, 2024 12:00 PM GMT
Tonix appoints two executives with decades of experience successfully launching and commercializing new CNS products Bradley Raudabaugh, MBA, joins as Vice President, Marketing, bringing over 25 years of marketing, sales and product planning experien
Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference
GlobeNewswire Inc.
Nov 26, 2024 12:00 PM GMT
CHATHAM, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, announced toda